Skip to main content

Table 1 Patient demographics

From: Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

 

Cases (n = 83)

Controls (n = 110)

Gendera

 Male

68 (81.9%)

62 (56.4%)

 Female

15 (18.1%)

48 (43.6%)

Ageb

 Median

69

61

 Range

42–88

24–88

Smoking statusc

 Yes

74 (89.2%)

62 (66%)

 No

9 (10.8%)

32 (33%)

Diagnosis

 Healthy

 

35

 Benign Pathology

 

75

  RI

 

53 (70.7%)

  ILD

 

17 (22.6%)

  Nodule

 

4 (5.3%)

  ICC

 

1 (1.3%)

 NSCLC Histology

  ADC

40 (48.2%)

 

  SCC

26 (31.3%)

 

  LCC

14 (16.9%)

 

  BAC

2 (2.4%)

 

  ND

1 (1.2%)

 

 NSCLC Stage

  I

18 (21.7%)

 

  II

6 (7.2%)

 

  III

22 (26.5%)

 

  IV

37 (44.6%)

 
  1. RI Respiratory Infection, ILD Interstitial Lung Disease, ICC Congestive Heart Failure, NSCLC Non-Small Cell Lung Cancer, ADC Adenocarcinoma, SCC Squamous Cell Carcinoma, LCC Large Cell Carcinoma, BAC Bronchioloalveolar Carcinoma, ND Not Differentiated Carcinoma
  2. aGender distribution between cancer and controls statistically significant: P < 0.001 (Fisher test)
  3. bStatistically significant differences in age between cancer and controls: P = 0.001 (Mann-Whitney U test)
  4. cSmoking status distribution between cancer and controls statistically different: P < 0.001 (Fisher test)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us